Contribute Try STAT+ Today

Medical marijuana has stepped onto the global stage.

In what appears to be a first for marijuana and a major pharmaceutical company, a Novartis subsidiary and a Canadian producer of medical cannabis products have agreed to market them around the world.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
    • The medical marijuana container(s), for which there are several different types of containers, requires a protocol for the product to be safely stored using a unique approach to removing the oxygen from the vessels. Therefore, medical marijuana has a different way to store the products so the patients receive the purest form of their medication.

      From what I know, one is only able to purchase medical marijuana from a point of purchase location, the law requires a physician’s prescription, in the state where one resides.

Comments are closed.